Data as of 11:01am ET
| +0.02 / +0.12%|
The 7 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a +16.48% increase from the last price of 17.17.
The current consensus among 7 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.